Clinical Trial Update: Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating bi-weekly administration of docetaxel in older men with hormone-refractory prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Geriatric Oncology Consortium | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED